Groupama Asset Managment Sells 30,313 Shares of HCA Healthcare, Inc. $HCA

Groupama Asset Managment decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 50.0% during the 3rd quarter, Holdings Channel.com reports. The firm owned 30,310 shares of the company’s stock after selling 30,313 shares during the period. Groupama Asset Managment’s holdings in HCA Healthcare were worth $12,918,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Cerity Partners LLC raised its position in shares of HCA Healthcare by 13.1% in the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock valued at $18,719,000 after buying an additional 5,092 shares in the last quarter. Swiss National Bank raised its holdings in HCA Healthcare by 4.3% in the 2nd quarter. Swiss National Bank now owns 558,900 shares of the company’s stock valued at $214,115,000 after acquiring an additional 23,100 shares in the last quarter. National Pension Service grew its holdings in shares of HCA Healthcare by 2.9% during the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after purchasing an additional 17,531 shares in the last quarter. Savant Capital LLC raised its stake in HCA Healthcare by 37.7% in the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock valued at $1,938,000 after purchasing an additional 1,246 shares in the last quarter. Finally, Sector Gamma AS grew its stake in HCA Healthcare by 36.0% during the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock worth $4,638,000 after buying an additional 2,883 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the firm’s stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares in the company, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,214 shares of company stock valued at $7,797,595 over the last 90 days. 1.30% of the stock is owned by corporate insiders.

HCA Healthcare Stock Down 1.5%

Shares of HCA opened at $502.08 on Thursday. The business has a 50-day simple moving average of $509.18 and a two-hundred day simple moving average of $472.27. HCA Healthcare, Inc. has a 12-month low of $314.43 and a 12-month high of $556.52. The stock has a market cap of $112.25 billion, a PE ratio of 17.69, a PEG ratio of 1.56 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the prior year, the firm posted $6.22 earnings per share. The firm’s revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.99%.

Analyst Ratings Changes

A number of analysts have recently weighed in on HCA shares. Barclays upped their price target on shares of HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. Leerink Partners upped their target price on HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 29th. Mizuho raised their price objective on HCA Healthcare from $540.00 to $585.00 and gave the company an “outperform” rating in a research note on Wednesday, February 25th. Finally, Oppenheimer increased their target price on shares of HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Sixteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $537.73.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.